Related Experiment Video
Updated: Jun 15, 2026
05:10
Three-dimensional Quantification of Intestinal Mucus Using Whole-mount Tissue Imaging
Published on: September 12, 2025
Gastric mucosal defense and cytoprotection.
Zsolt Tulassay1, László Herszényi
1Second Department of Medicine, Semmelweis University Budapest, H-1088 Budapest, Szentkirályi str. 46, Hungary. tulassay@bel2.sote.hu
Best Practice & Research. Clinical Gastroenterology
|March 16, 2010
Summary
The gastric mucosa has defense mechanisms to protect against damage from various harmful factors. Understanding these gastric mucosal defense strategies aids in developing therapies for gastrointestinal injury.
Area of Science:
- Gastroenterology
- Physiology
- Pharmacology
Background:
- The gastric mucosa faces constant exposure to damaging agents like extreme temperatures, pH variations, and cytotoxic substances.
- Bacterial products can trigger local and systemic inflammatory responses, challenging mucosal integrity.
- Mucosal defense encompasses a complex, multifactorial system that maintains gastric tissue intactness.
Purpose of the Study:
- To review the fundamental components of gastric mucosal defense mechanisms.
- To highlight the role of cytoprotection in mitigating gastric damage.
- To connect knowledge of defense mechanisms to therapeutic strategies.
Main Methods:
- Literature review of established and emerging concepts in gastric mucosal defense.
- Analysis of factors contributing to mucosal integrity and injury.
- Examination of the pharmacological concept of cytoprotection.
Main Results:
- Gastric mucosal defense is a multifactorial process influenced by numerous substances and mediators.
- Pharmacological agents can exhibit cytoprotection, reducing stomach damage from ulcerogenic agents.
- Understanding these mechanisms is crucial for developing gastrointestinal protective therapies.
Conclusions:
- Gastric mucosal defense is essential for protecting the stomach lining from endogenous and exogenous aggressors.
- The study of cytoprotection offers a pathway for pharmaceutical interventions against gastric injury.
- Further research into mucosal defense mechanisms promises novel therapeutic approaches for gastrointestinal disorders.
Related Concept Videos
01:25Mucosal Barrier of the Stomach
The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining. Bicarbonate,...
01:24Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
01:18Surface Membrane Barriers
The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
01:28Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.